Autophagy Impairment in Parkinson’s Disease: Approaches to Therapy
-
Published:2025-02
Issue:1
Volume:59
Page:51-68
-
ISSN:0026-8933
-
Container-title:Molecular Biology
-
language:en
-
Short-container-title:Mol Biol
Publisher
Pleiades Publishing Ltd
Reference156 articles.
1. Rocca W.A. 2018. The burden of Parkinson’s disease: A worldwide perspective. Lancet Neurol.
17 (11), 928‒929. https://doi.org/10.1016/S1474-4422(18)30355-7
2. Dorsey E.R., Bloem B.R. 2018. The Parkinson pandemic—a call to action. JAMA Neurol.
75, 9‒10.
3. Leentjens A.F.G., Dujardin K., Pontone G.M., Starkstein S.E., Weintraub D., Martinez-Martin P. 2014. The Parkinson anxiety scale (PAS): Development and validation of a new anxiety scale. Mov. Disord. 29 (8), 1035‒1043. https://doi.org/10.1002/mds.25919
4. Ben-Shlomo Y., Darweesh S., Llibre-Guerra J., Marras C., San Luciano M., Tanner C. 2024. The epidemiology of Parkinson’s disease. Lancet. 403 (10423), 283‒292. https://doi.org/10.1016/S0140-6736(23)01419-8
5. He S., Zhong S., Liu G., Yang J. 2021. Alpha-synuclein: The interplay of pathology, neuroinflammation, and environmental factors in Parkinson’s disease. Neurodegener. Dis.
20 (2‒3), 55‒64. https://doi.org/10.1159/000511083